CSS
AMRI

Cubist Systematic Strategies’s Albany Molecular Research Inc AMRI Stock Holding History

Cubist Systematic Strategies’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-25,096
Closed -$507K – 2146
2015
Q2 		$507K Buy
+25,096
New +$484K 0.02% 959
2015
Q1 		– Sell
-23,800
Closed -$387K – 2210
2014
Q4 		$387K Buy
+23,800
New +$437K 0.02% 1034

Other funds holding AMRI

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cubist Systematic Strategies's AMRI Position: Q3 2015 in Review

Cubist Systematic Strategies sold out of Albany Molecular Research Inc (AMRI) in Q3 2015, closing a stake of 25,096 shares — an estimated $507K sold.

Cubist Systematic Strategies first reported a position in AMRI in Q4 2014 and held it in 2 quarters. The position peaked at $507K in Q2 2015. 143 funds tracked by Wall St. Rank hold AMRI as of Q3 2015.

  • Cubist Systematic Strategies reported no remaining Albany Molecular Research Inc position as of Q3 2015 after selling out during the quarter.
  • Cubist Systematic Strategies sold 25,096 Albany Molecular Research Inc shares in Q3 2015, an estimated $507K.
  • Cubist Systematic Strategies first reported a position in Albany Molecular Research Inc in Q4 2014 and held it in 2 quarters.
  • Cubist Systematic Strategies's Albany Molecular Research Inc position peaked at $507K in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2015.

Based on Cubist Systematic Strategies's 13F filing for Q3 2015, filed 16 Nov 2015.